Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.10%53.920.9%$1406.70m
JNJJohnson & Johnson -0.05%179.460.7%$1295.87m
BMYBristol-Myers Squibb Co. 0.00%77.591.0%$1212.16m
MRKMerck & Co., Inc. -0.20%92.140.7%$1164.75m
ABBVAbbVie, Inc. 0.21%150.871.9%$1102.57m
LLYEli Lilly & Co. 0.19%314.081.1%$969.13m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.14%142.980.0%$491.89m
AZNAstraZeneca Plc -0.14%66.611.0%$490.84m
NVSNovartis AG 0.01%91.270.2%$259.87m
VERUVeru, Inc. 1.90%12.880.0%$258.52m
GSKGlaxoSmithKline Plc -0.12%44.360.2%$257.24m
HZNPHorizon Therapeutics Plc -0.36%90.265.4%$195.32m
SGENSeagen Inc. 1.46%140.485.7%$188.37m
NVONovo Nordisk A/S -0.58%106.000.1%$181.83m
VTRSViatris, Inc. 0.00%12.010.0%$165.27m

Company Profile

Clinical-stage biotech focused on cardiovascular, central nervous system, inflammatory and metabolic diseases. Their leading drug candidate is lorcaserin hydrochloride, which recently received positive data from a clinical trial. They are headquartered in San Diego, CA.